Zebra Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25,250
| Closed | -$784K | – | 94 |
|
|
2022
Q2 | $784K | Buy |
25,250
+3,139
| +14% | +$97.5K | 2.3% | 6 |
|
|
2022
Q1 | $908K | Buy |
22,111
+1,520
| +7% | +$62.4K | 2.09% | 6 |
|
|
2021
Q4 | $895K | Sell |
20,591
-6,869
| -25% | -$299K | 1.43% | 16 |
|
|
2021
Q3 | $1.38M | Buy |
27,460
+8,545
| +45% | +$428K | 1.67% | 7 |
|
|
2021
Q2 | $1.19M | Sell |
18,915
-2,042
| -10% | -$129K | 1.4% | 15 |
|
|
2021
Q1 | $1.95M | Buy |
+20,957
| New | +$1.95M | 2.14% | 2 |
|
|
2020
Q3 | – | Sell |
-4,577
| Closed | -$362K | – | 196 |
|
|
2020
Q2 | $362K | Buy |
4,577
+7
| +0.2% | +$554 | 0.52% | 65 |
|
|
2020
Q1 | $264K | Sell |
4,570
-327
| -7% | -$18.9K | 0.43% | 99 |
|
|
2019
Q4 | $264K | Sell |
4,897
-153
| -3% | -$8.25K | 0.23% | 182 |
|
|
2019
Q3 | $264K | Buy |
+5,050
| New | +$264K | 0.29% | 130 |
|
|
2018
Q4 | – | Sell |
-4,697
| Closed | -$309K | – | 392 |
|
|
2018
Q3 | $309K | Buy |
+4,697
| New | +$309K | 0.14% | 292 |
|
|
2018
Q2 | – | Sell |
-8,066
| Closed | -$425K | – | 336 |
|
|
2018
Q1 | $425K | Buy |
8,066
+1,050
| +15% | +$55.3K | 0.15% | 255 |
|
|
2017
Q4 | $326K | Buy |
7,016
+275
| +4% | +$12.8K | 0.11% | 282 |
|
|
2017
Q3 | $273K | Buy |
+6,741
| New | +$273K | 0.09% | 238 |
|